Andres Abin-Fuentes, Ph.D., is a Senior Director, Biopharmaceutical Development, Deerfield Discovery and Development and joined the Firm in 2024. Prior to Deerfield, Dr. Abin-Fuentes was a Director, Biologics & Gene Therapy Process Development & Manufacturing for Cartesian Therapeutics (and formerly Selecta Biosciences) for three years. Before Cartesian, he was with Synlogic, Inc., for three years, most recently as Head of Bioprocess Development. Dr. Abin-Fuentes has also held roles with Vertex Pharmaceuticals, Inc., Goodwin Biotechnology, Inc., Bristol-Myers Squibb. Dr. Abin-Fuentes holds a B.S. in Chemical Engineering from the University of Minnesota-Twin Cities, an M.Sc. in Chemical Engineering and a Ph.D. in Chemical Engineering Practices from the Massachusetts Institute of Technology, an M.B.A. from the University of Nebraska, and an M.S. in Data Science from Eastern University.
Launched in 1994, Deerfield Management Company is an investment firm dedicated to advancing healthcare through information, investment, and philanthropy—all toward the end goal of cures for disease, improved quality of life, and reduced cost of care.
Read More
Investment
Supporting companies across the healthcare ecosystem with flexible funding models…
Read MoreFeatured
Deerfield Management and the University of North Carolina Eshelman School of Pharmacy Launch Biotherapeutics Certificate Program Bridging Academia and Industry Deerfield Management Launches Joint Venture with Horizon Blue Cross Blue Shield of New Jersey Elion Therapeutics Closes $81 Million Series B Funding Round Led by Deerfield Management and AMR Action Fund
Portfolio Companies
Deerfield generally maintains a combined portfolio of more than 150 private and public investments across the life science, medical device, diagnostic, digital health and health service industries at all stages of evolution from start-up to mature company.
Read More View Portfolio Companies
Research Collaborations
Deerfield partners with leading academic research centers, providing critical funding and expertise to further sustain and accelerate the commercialization of discoveries toward meaningful societal impact by advancing cures for disease.
Read More View Research Collaborations
Strategic Partners
As a strategic partner, Deerfield offers capital, scientific expertise, business operating support, and unique access to innovation.
Read More
Deerfield Foundation
The Deerfield Foundation is a New York City-based not-for-profit organization whose mission is to improve health, accelerate innovation and promote human equity.
Read More Meet the Foundation TeamFoundation Partners by Focus
Children's Health Diversity Initiatives Maternal Health View AllFounded Diversity Programs
Break into the Boardroom Fellowships Science to the Street (formerly Women in Science)
Cure Campus
Cure is a 12-story innovation campus in New York City that intends to bring together innovators from academia, government, industry, and the not-for-profit sectors to advance human health and accelerate the fight against disease.
Read More Join the Cure Email ListCure Programming
Cure has a series of expert lectures intended to advance thought in healthcare, management, innovation, policy, and other relevant subjects. This fosters growth and education for those at Cure and its guests.
Events at the Cure
